Live Breaking News & Updates on Nikhilc Munshi

Stay updated with breaking news from Nikhilc munshi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Paving the Path to Progress in Multiple Myeloma Research

A fascination with laboratory research paired with hard work and dedication led to Nikhil C. Munshi, MD, becoming a pioneer in multiple myeloma treatment. ....

Little Rock , United States , Roberta Kyle , Mehmetk Samur , Nikhilc Munshi , Medha Munshi , Kennethc Anderson , Tarun Srivastava , Lawrence Einhorn , Maharaja Sayajirao University , Johns Hopkins Cancer Center , Sidney Kimmel Comprehensive Cancer Center , Dana Farber Cancer Institute , Drbc Roy National Award , Most Distinguished Lifetime Achievement In Myeloma Research , International Myeloma Society , National Institutes Of Health , Indiana University , Jerome Lipper Multiple Myeloma Center , Harvard Medical School , Cancer Care , Kraft Family Chair , Born Passion , Studying Hematologic , Sidney Kimmel Comprehensive Cancer , Treatment Options ,

Kronos Bio Inc. (KRON) Issues Pipeline Update and p300 KAT Inhibitor Development Candidate

Kronos Bio Inc. (KRON) Issues Pipeline Update and p300 KAT Inhibitor Development Candidate
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kronos Bio , Nikhilc Munshi , Christopher Dinsmore , Norbert Bischofberger , Kronos Bio Inc , Jerome Lipper Multiple Myeloma Center , Dana Farber Cancer ,

Dr Munshi on the Background of the CARTITUDE-1 Trial in Multiple Myeloma

Nikhil C. Munshi, MD, discusses the background of the phase 1b/2 CARTITUDE-1 trial of ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma and highlights the specific patient population enrolled in the study.
....

Nikhilc Munshi , Dana Farber Cancer Institute , Medicine At Harvard Medical School , Correlative Science , Jerome Lipper Multiple Myeloma Center , Kraft Family Chair , Multiple Myeloma Immune Effector Cell Therapy , Harvard Medical School , Multiple Myeloma , Onclive Tv ,

Dr Munshi on Implications of Findings From the CARTITUDE-1 Trial of Cilta-Cel in Myeloma

Dr Munshi on Implications of Findings From the CARTITUDE-1 Trial of Cilta-Cel in Myeloma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Nikhilc Munshi , Dana Farber Cancer Institute , Medicine At Harvard Medical School , Correlative Science , Jerome Lipper Multiple Myeloma Center , Kraft Family Chair , Multiple Myeloma Immune Effector Cell Therapy , Harvard Medical School ,

Cilta-Cel Provides Sustained Efficacy and Safety in Relapsed/Refractory Multiple Myeloma

Nikhil C. Munshi, MD, discusses the significance of the FDA approval of cilta-cel in patients with multiple myeloma, shared the long-term findings from the pivotal CARTITUDE-1 trial, and highlighted future directions for CAR T-cell therapy in this disease. ....

United States , Dana Farber Cancer Institute , Nikhilc Munshi , Jerome Lipper Multiple Myeloma Center , Harvard Medical School , Correlative Science , Kraft Family Chair , Multiple Myeloma Immune Effector Cell Therapy , Adaptive Biotechnologies , Karyopharm Therapeutics ,